Spaulding, Caitlin N.
Klein, Roger D.
Schreiber, Henry L. IV
Janetka, James W.
Hultgren, Scott J.
Article History
Received: 25 October 2017
Revised: 17 January 2018
Accepted: 24 January 2018
First Online: 27 February 2018
Competing interests
: S.J.H. and J.W.J. have ownership interest in Fimbrion Therapeutics, and may benefit if the company is successful in marketing mannosides. The remaining authors declare no competing interests.